Insider Buying: ASP Isotopes Inc. (NASDAQ:ASPI) Director Buys 4,313 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Robert John Andrew Ryan bought 4,313 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The stock was acquired at an average cost of $3.20 per share, with a total value of $13,801.60. Following the transaction, the director now owns 555,868 shares of the company’s stock, valued at approximately $1,778,777.60. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Robert John Andrew Ryan also recently made the following trade(s):

• On Thursday, April 25th, Robert John Andrew Ryan purchased 9,500 shares of ASP Isotopes stock. The shares were acquired at an average cost of $3.42 per share, for a total transaction of $32,490.00.

ASP Isotopes Trading Up 9.1 %

Shares of ASP Isotopes stock opened at $3.72 on Friday. The stock has a market cap of $181.98 million, a P/E ratio of -7.59 and a beta of 5.15. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.01. ASP Isotopes Inc. has a 12-month low of $0.28 and a 12-month high of $4.97. The business’s 50 day moving average is $3.71 and its 200-day moving average is $2.56.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings results on Wednesday, April 10th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.43 million for the quarter. Equities research analysts predict that ASP Isotopes Inc. will post -0.11 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, HC Wainwright lifted their target price on ASP Isotopes from $5.25 to $5.50 and gave the company a “buy” rating in a research report on Wednesday, April 17th.

Institutional Investors Weigh In On ASP Isotopes

An institutional investor recently bought a new position in ASP Isotopes stock. Rathbones Group PLC purchased a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 151,750 shares of the company’s stock, valued at approximately $272,000. Rathbones Group PLC owned 0.31% of ASP Isotopes as of its most recent filing with the Securities & Exchange Commission. 16.80% of the stock is currently owned by institutional investors and hedge funds.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.